This study exists to compare options and see whether the medication ALTO-207 offers something meaningfully different. For people living with Depression, that matters because care needs to work in daily life, not just in theory.
This study is looking at whether a digital support tool can help people with Treatment Resistant Depression or depression. Participants take part in a digital support tool and complete follow-up assessments.
In United States
Why is this study shown?
This study is directly about Depression.
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 65 Years
This study is looking at whether Ketamine can help people with Healthy, depression, or Treatment Resistant Depression. Participants take part in Ketamine and complete follow-up assessments.
This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at test a personalized approach to brain stimulation as an intervention for depression. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether POWER-MS can help people with Multiple Sclerosis or depression. Participants take part in POWER-MS and complete follow-up assessments.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.